JPX:3649

FINDEX Inc. · JPX · Healthcare · JPY · FY for 2025

Figures on this page computed 2026-11-08 13:35 UTC

Last close

n/aJPY

Market data

16.6xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
JPY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
20.6%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2025
- Computed from the filing for 2025
26.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2025
- Computed from the filing for 2025
2.0%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
JPY
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

All from 100

lens 2 of 9

Sales

186

2016-12-31 to 2025-12-31100 at the start186

Sales: 100.00 on 2016-12-31 to 185.82 on 2025-12-31, up 86%.

Profit

251

2016-12-31 to 2025-12-31100 at the start251

Profit: 100.00 on 2016-12-31 to 251.44 on 2025-12-31, up 151%.

Shares in issue

95.3

2016-12-31 to 2025-12-31100 at the start95.3

Shares in issue: 100.00 on 2016-12-31 to 95.27 on 2025-12-31, down 5%.

Sales is at 186, Profit is at 251, Shares in issue is at 95, against 100 in 2016.

Sales is at 186, Profit is at 251, Shares in issue is at 95, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100186
Source
computed
Statement
income
Fiscal year
2025
Reported in
JPY
Profit, where the first year is 100251
Source
computed
Statement
income
Fiscal year
2025
Reported in
JPY
Shares in issue, where the first year is 10095
Source
computed
Statement
income
Fiscal year
2025
Reported in
JPY